Ozanimod Hydrochloride
Brand name: Zeposia
Rank #491 of 500 drugs by total cost
$14.2M
Total Cost
1,535
Total Claims
$14.2M
Total Cost
79
Prescribers
$9,265
Cost per Claim
14
Beneficiaries
1,636
30-Day Fills
$180K
Avg Cost/Provider
19
Avg Claims/Provider
About Ozanimod Hydrochloride
Ozanimod Hydrochloride (sold as Zeposia) was prescribed 1,535 times by 79 Medicare Part D providers in 2023, costing the program $14.2M. At $9,265 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 488 | Eteplirsen (Exondys-51) | $14.4M | 192 |
| 489 | Colesevelam Hcl (Colesevelam Hcl) | $14.3M | 50,268 |
| 490 | Bexarotene (Bexarotene) | $14.2M | 1,613 |
| 491 | Ozanimod Hydrochloride (Zeposia) | $14.2M | 1,535 |
| 492 | Enoxaparin Sodium (Enoxaparin Sodium) | $14.2M | 93,202 |
| 493 | Omadacycline Tosylate (Nuzyra) | $14.1M | 1,395 |
| 494 | Binimetinib (Mektovi) | $14.1M | 1,094 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology